Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

Clinical trial NCT02751710 · COMPLETED

Trial details

NCT number: NCT02751710
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)Stage IIb Breast Cancer (T3N0)

Start date: 2016-12-06
Primary completion: 2023-03-31
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.